Muscle paresis and hypokalemia after treatment with duogastrone.
D000328:Adult; D002214:Capsules; D003402:Creatine Kinase / Q000097:blood; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006035:Glycyrrhiza / Q000187:drug effects*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D008297:Male; D009212:Myoglobinuria / Q000209:etiology; D009336:Necrosis; D010243:Paralysis / Q000139:chemically induced*; D010946:Plants, Medicinal; D013729:Terpenes / Q000008:administration & dosage / Q000009:adverse effects*
D002214:Capsules; D013729:Terpenes; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase